Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Non-Therapeutic Biomolecules Market Growth Potential: How Will Market Size Shift Through 2030?
The non-therapeutic biomolecules market has experienced significant expansion in its size over recent years. It is projected to expand from $33.92 billion in 2025 to $37.59 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.8%. The historical period’s expansion is primarily attributable to factors like an escalating demand for research biomolecules, augmented adoption in in vitro diagnostics, advancements in pharmaceutical research, developments in recombinant protein technology, and a rise in collaborations between biotech firms.
The non-therapeutic biomolecules market is anticipated to experience substantial expansion over the coming years. Its size is projected to reach $56.43 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. This projected increase during the forecast period stems from factors such as the broader application of synthetic biomolecules, rising investments in precision medicine, increased adoption within agricultural biotechnology, a growing emphasis on environmentally friendly and scalable biomolecule manufacturing, and advancements in automated biomolecule synthesis platforms. Key developments expected during this period encompass advanced protein engineering, high-throughput screening technologies, sustainable methods for biomolecule production, cell-free biomolecule synthesis, and customizable biomolecule platforms.
Get A Free Sample Report With In-Depth Market Insights:
Non-Therapeutic Biomolecules Market Growth Drivers: What’s Behind The Acceleration?
The expansion of the non-therapeutic biomolecules market is expected to be propelled by the rapidly increasing volume of research and laboratory testing. Laboratory testing refers to a medical procedure involving the analysis of a blood, urine, or other bodily substance sample to determine and monitor diseases and to formulate a treatment plan. Conversely, research involves the creation of new knowledge or the creative application of current knowledge to generate novel concepts, theories, and understandings. In laboratory testing, non-therapeutic biomolecules are employed to measure the presence or concentration of a biomarker molecule indicating disease, which serves to enhance the sensitivity and specificity of the test. For instance, in July 2024, the National Health Service (NHS), a UK-based hospital and health care provider, reported that diagnostic activity exceeded pre-pandemic levels in 2023, noting a 21% increase in tests performed in May 2024 compared to 2023. Therefore, the significant rise in research and laboratory testing is a key driver for the growth of the non-therapeutic biomolecules market.
Non-Therapeutic Biomolecules Market Segment Analysis: What Are The Core Market Categories?
The non-therapeutic biomolecules market covered in this report is segmented –
1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)
3) By Application: Diagnostic Equipment, Therapeutic Equipment, Monitoring Or Imaging Equipment, Laboratory Or Research Equipment, Rehabilitation Or Mobility Support
Subsegments:
1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides
6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies
Non-Therapeutic Biomolecules Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the non-therapeutic biomolecules market are concentrating on developing novel cell separation technology to boost throughput and refine processes, thus gaining a competitive edge. These innovative research-only kits are designed to furnish scientists with a critical solution to biological and lab workflow challenges. For example, in May 2023, AcouSort AB, a Sweden-based biotechnology company, unveiled the AcouTrap 3 system. This system integrates the distinct characteristics of acoustofluidics, which merges sound waves with microfluidics, to provide an efficient solution for isolating cells and extracellular vesicles in a single workflow. The AcouTrap 3 system utilizes gentle acoustic trapping technology, empowering scientists to process more samples with enhanced cell viability and minimal loss compared to conventional column- or bead-based techniques, consequently improving productivity and streamlining laboratory operations.
Non-Therapeutic Biomolecules Market Top Companies Driving Competitive Growth
Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Eppendorf AG, Bio-Techne Corporation, Vectalys, Avid Bioservices Inc.
View The Full Non-Therapeutic Biomolecules Market Report:
Non-Therapeutic Biomolecules Market Geographic Analysis: Where Is Demand Rising Fastest?
Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2025. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
